Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID PNA/COVID 19 PNA/Covid test result=Positive; COVID PNA/COVID 19 PNA/Covid test result=Positive; This is a spontaneous report from a contactable consumer ((patient Daughter).  A 73-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot Number: EN6201) as single dose,  and dose 1 via an unspecified route of administration on 23Jan2021 (Batch/Lot Number: E18982) as single dose for covid-19 immunisation.  Medical history included hypertension, hyperlipidaemia , type 2 diabetes mellitus , coronary artery disease , coronary artery bypass, chronic kidney disease,  post-traumatic stress disorder, depression. Concomitant medications included amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; hydralazine hydrochloride (APRESOLINE) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (ASPRIN) taken for an unspecified indication, start and stop date were not reported; atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported; clopidogrel (CLOPIDOGREL) taken for an unspecified indication, start and stop date were not reported; furosemide (FUROSEMIDE) taken for an unspecified indication, start and stop date were not reported; gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported; gramicidin, neomycin sulfate, nystatin, triamcinolone acetonide (KENALOG COMP. MED MYCOSTATIN) taken for an unspecified indication, start and stop date were not reported; ketoconazole (KETOCONAZOLE) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported; metoprolol tartrate (METOPROLOL TARTRAS) taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; insulin human, insulin human injection, isophane (NOVOLIN 70/30) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; vitamin C (ASCORBIC ACID) taken for an unspecified indication, start and stop date were not reported; vitamin E nos (VITAMIN E) taken for an unspecified indication, start and stop date were not reported.  The patient previously took morphine and experienced drug hypersensitivity, doxycycline and experienced drug hypersensitivity.  The patient experienced covid pna//covid test result=positive  on 17Apr2021 , causing patient's death on 07May2021.  The patient was hospitalized for covid 19 pna/covid test result=positive  for 20 days.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive   on 17Apr2021   , sars-cov-2 test: positive   on 04May2021. The patient died on 07May2021.  An autopsy was not performed.  Course of the event. The week prior to 17Apr2021 the patient  started with diarrhea and cough. During the week it progressed to Vomiting, diarrhea and cough. He was unable to hold down any food or fluids. His diarrhea was uncontrollable with many accidents. On 17Apr21 he became SOB, cough, weak.  He was taken to hospital ER where he was diagnosed with COVID PNA. He was admitted into the hospital for 20 days and passed away 07May2021 from COVID 19 PNA, acute hypoxc respiratory failure, SARS. The patient was treated with the following drugs: remdesivir, decadron, zithromax, cefepime, rocephin, BIPAP, intubation, dexamethasone, insulin, vanc.  Follow up information has been requested. Lot numbers already provided.; Reported Cause(s) of Death: SARS; COVID-19 pneumonia; Hypoxia; Acute respiratory failure